Purpose: To ascertain whether bimodal psychosis (i.e., independent postictal and interictal psychosis) in patients with epilepsy can be characterized by postictal psychosis that develops after interictal psychosis remits.

Methods: We reviewed the records of 14 patients with bimodal psychosis treated at a national center hospital. Clinical and psychopathological characteristics of the patients were examined.

Results: Among the 14 patients with bimodal psychosis, four initially had interictal psychosis, and 10 initially had postictal psychosis. That is, interictal-antecedent bimodal psychosis characterized four cases, and postictal-antecedent bimodal psychosis characterized 10 cases. Patients with interictal-antecedent bimodal psychosis composed 2.2% of the total patients with epilepsy and psychosis (n = 180) and 28.5% of total patients with bimodal psychosis. All four patients with interictal-antecedent bimodal psychosis had partial epilepsy with complex partial seizures, bilateral EEG abnormalities, and borderline (or decreased) intellectual functioning. Most of these clinical features are common to both types of bimodal psychosis. Among patients with interictal-antecedent bimodal psychosis, the mean age at the onset of the initial symptoms was 10.8 years (SD, 4.3 years) for epilepsy, 24.4 (6.1) years for interictal psychosis, and 33.8 (4.5) years for postictal psychosis.

Conclusions: In a few patients, postictal psychosis develops after the remission of interictal psychosis. Interictal-antecedent bimodal psychosis is not likely a discrete entity because of several characteristics common to both types of bimodal psychosis. Patients may have greater vulnerability to psychosis and develop psychotic episodes easily, regardless of the presence of preceding seizures.

Download full-text PDF

Source
http://dx.doi.org/10.1046/j.1528-1157.2003.66702.xDOI Listing

Publication Analysis

Top Keywords

bimodal psychosis
52
psychosis
25
interictal psychosis
24
interictal-antecedent bimodal
20
postictal psychosis
16
psychosis patients
16
bimodal
13
patients bimodal
12
patients interictal-antecedent
12
patients
11

Similar Publications

Article Synopsis
  • Sound frequency and duration play crucial roles in how our brain detects prediction errors, helping us respond swiftly to changing auditory environments.
  • An electrocorticography study with 13 participants revealed significant activation in certain brain regions during frequency and duration tasks, highlighting their connection to prediction errors.
  • Differences in the brain's response patterns between duration and frequency tasks suggest distinct processing mechanisms, which may help explain certain auditory processing challenges in psychiatric disorders.
View Article and Find Full Text PDF

Focal impaired awareness seizures (FIAS), previously known as complex partial seizures, refer to focal seizures that start in one hemisphere of the brain and are associated with an impairment in consciousness. FIAS of temporal lobe origin most often present with psychopathology, such as behavioral and affective symptoms. It has a bimodal age distribution peaking at the extremes of life.

View Article and Find Full Text PDF

Objective: To establish clinico-pathogenetic ratios of delusional psychoses constituting the psychopathological space of paranoid schizophrenia and to determine clinical and pathogenetic validity of concepts of a single delusional psychosis (a model of chronic delusion with a staged course) and two endogenous delusional psychoses.

Material And Methods: A sample consisted of 56 patients (19 women, 37 men; the average age 39.7±9.

View Article and Find Full Text PDF
Article Synopsis
  • There is variability in treatment-resistant schizophrenia (TRS), with some individuals never responding to treatment and others becoming resistant after an initial response, suggesting different underlying causes.
  • The study aimed to identify sociodemographic and clinical factors related to the early onset of TRS using a retrospective analysis of a cohort from the South London and Maudsley.
  • Results indicated a median treatment time to TRS of about 3 years and 8 months, with more severe initial positive symptoms leading to earlier TRS onset, while long-acting injectable antipsychotics were linked to a later onset.
View Article and Find Full Text PDF

Outcomes in treatment-resistant schizophrenia: symptoms, function and clozapine plasma concentrations.

Ther Adv Psychopharmacol

October 2021

National Psychosis Service, South London and Maudsley NHS Foundation Trust, London, UK.

Background: Clozapine is the only medication licenced for treating patients with treatment-refractory schizophrenia. However, there are no evidence-based guidelines as to the optimal plasma level of clozapine to aim for, and their association with clinical and functional outcome.

Objective: We assessed the relationship between clinical and functional outcome measures and blood concentrations of clozapine among patients with treatment-refractory psychosis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!